EP2870172 - EXTRACELLULAR MATRIX HEPARIN-BINDING DOMAINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.05.2017 Database last updated on 31.08.2024 | |
Former | Examination is in progress Status updated on 31.01.2017 | Most recent event Tooltip | 12.05.2017 | Application deemed to be withdrawn | published on 14.06.2017 [2017/24] | Applicant(s) | For all designated states École Polytechnique Fédérale de Lausanne (EPFL) EPFL-TTO EPFL Innovation Park J 1015 Lausanne / CH | [N/P] |
Former [2015/20] | For all designated states Ecole Polytechnique Fédérale de Lausanne (EPFL) EPFL-TTO EPFL Innovation Park J 1015 Lausanne / CH | Inventor(s) | 01 /
HUBBELL, Jeffrey A. 4837 South Kimbark Avenue Chicago, IL 60615-1915 / UA | 02 /
MARTINO, Mikaël Ch. de la Redoute 20 CH-1260 Nyon / CH | 03 /
DE LAPORTE, Laura Konig Albertlaan 12 B-9840 De Pinte / BE | 04 /
RICE, Jeffrey J. 1498 Parkway Drive Cookeville, TN 35801 / US | 05 /
TORTELLI, Federico Hebelplatz 3 CH-4056 Basel / CH | [2015/24] |
Former [2015/20] | 01 /
HUBBELL, Jeffrey A. 4837 South Kimbark Avenue Chicago, IL 60615-1915 / UA | ||
02 /
MARTINO, Mikaël Ch. de la Redoute 20 CH-1260 Nyon / CH | |||
03 /
DE LAPORTE, Laura Konig Albertlaan 12 B-9840 De Pinte / BE | |||
04 /
RICE, Jeffrey J. 1498 Parkway Drive Cookeville, TN 35801 / US | |||
05 /
TORTELLI, Federico Av d-Echallens 56 CH-1004 Lausanne / CH | Representative(s) | dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | [N/P] |
Former [2015/20] | Von Kreisler Selting Werner - Partnerschaft von Patentanwälten und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | Application number, filing date | 13732977.7 | 03.07.2013 | WO2013EP64023 | Priority number, date | US201261667634P | 03.07.2012 Original published format: US 201261667634 P | [2015/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014006087 | Date: | 09.01.2014 | Language: | EN | [2014/02] | Type: | A1 Application with search report | No.: | EP2870172 | Date: | 13.05.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.01.2014 takes the place of the publication of the European patent application. | [2015/20] | Search report(s) | International search report - published on: | EP | 09.01.2014 | Classification | IPC: | C07K14/315 | [2015/20] | CPC: |
C07K14/75 (EP,US);
C07K14/4718 (US);
C07K14/78 (EP,US);
C07K2319/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/20] | Title | German: | EXTRAZELLULÄRE MATRIX MIT HEPARINBINDENDEN DOMÄNEN | [2015/20] | English: | EXTRACELLULAR MATRIX HEPARIN-BINDING DOMAINS | [2015/20] | French: | DOMAINES DE LIAISON À L'HÉPARINE DE MATRICE EXTRACELLULAIRE | [2015/20] | Entry into regional phase | 29.01.2015 | National basic fee paid | 29.01.2015 | Designation fee(s) paid | 29.01.2015 | Examination fee paid | Examination procedure | 29.01.2015 | Examination requested [2015/20] | 15.10.2015 | Amendment by applicant (claims and/or description) | 22.06.2016 | Despatch of a communication from the examining division (Time limit: M06) | 03.01.2017 | Application deemed to be withdrawn, date of legal effect [2017/24] | 01.02.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/24] | Divisional application(s) | EP16206356.4 / EP3202781 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.06.2016 | Fees paid | Renewal fee | 27.07.2015 | Renewal fee patent year 03 | 27.09.2016 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.07.2016 | 04   M06   Fee paid on   27.09.2016 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO03048185 (GENVEC INC [US], et al) [X] 1-49 * claim -; sequence 136 *; | [X]KR20060005595 (SEOUL NAT UNIV IND FOUNDATION [KR]) [X] 1-49 * the whole document *; | [A]WO2009038729 (REGENERX BIOPHARMACEUTICALS [US], et al) [A] 1-49 * the whole document *; | [XP] - LAURA DE LAPORTE ET AL, "Tenascin C Promiscuously Binds Growth Factors via Its Fifth Fibronectin Type III-Like Domain", PLOS ONE, (20130101), vol. 8, no. 4, doi:10.1371/journal.pone.0062076, ISSN 1932-6203, pages e62076 - e62076, XP055077343 [XP] 1-49 * the whole document * DOI: http://dx.doi.org/10.1371/journal.pone.0062076 | by applicant | US5227165 | US6022564 | US6090925 | US6224794 | US6331422 | US6607740 | US6723344 | US7241730 | US2007202178 | US2007264227 | US2008031899 | US2010003338 | US2010055189 | - J. BIOL. CHEM., (1969), vol. 243, pages 3552 - 3559 | - LUTOLF; HUBBELL, BIOMACROMOLECULES, (2003), vol. 4, pages 713 - 22 | - DEVALAPALLY ET AL., CANCER CHEMOTHER PHARMACOL. | - LANGER ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICS, (2003), vol. 257, pages 169 - 180 | - TOBIO ET AL., PHARMACEUTICAL RESEARCH, (1998), vol. 15, no. 2, pages 270 - 275 | - SCHONHERR E; HAUSSER HJ, "Extracellular matrix and cytokines: a functional unit", DEVELOPMENTAL IMMUNOLOGY, (2000), vol. 7, no. 2-4, pages 89 - 101 | - MARTINO MM; HUBBELL JA, "The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain", THE FASEB JOURNAL: OFFICIAL PUBLICATION OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, (2010), vol. 24, no. 12, pages 4711 - 4721 | - MARTINO MM; TORTELLI F; MOCHIZUKI M; TRAUB S; BEN-DAVID D; KUHN GA; MULLER R; LIVNE E; EMING SA; HUBBELL JA, "Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing", SCIENCE TRANSLATIONAL MEDICINE, (2011), vol. 3, no. 100, page 100RA189 | - KLEINMAN HK; PHILP D; HOFFMAN MP, "Role of the extracellular matrix in morphogenesis", CURR OPIN BIOTECHNOL, (2003), vol. 14, no. 5, pages 526 - 532 | - DISCHER DE; MOONEY DJ; ZANDSTRA PW, "Growth factors, matrices and forces combine and control stem cells", SCIENCE, (2009), vol. 324, pages 1673 - 1677 | - BERRIER AL; YAMADA KM, "Cell-matrix adhesion", J CELL PHYSIOL, (2007), vol. 213, pages 565 - 573 | - SCHULTZ GS; WYSOCKI A, "Interactions between extracellular matrix and growth factors in wound healing", WOUND REPAIR REGEN, (2009), vol. 17, pages 153 - 162 | - LINDAHL U; LI JP, "Interactions between heparan sulfate and proteins - design and functional implications", INT REV CELL MOLEC BIOL, (2009), vol. 276, pages 105 - 159 | - MAKARENKOVA HP; HOFFMAN MP; BEENKEN A; ELISEENKOVA AV; MEECH R; TASAU C; PATEL VN; LANG RA; MOHAMMADI M, "Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis", SCI SIGNAL, (2009), vol. 2, page RA55 | - TREBAUL A; CHAN EK; MIDWOOD KS, "Regulation of fibroblast migration by tenascin-C", BIOCHEM SOC TRANS, (2007), vol. 35, pages 695 - 697 | - OREND G, "Potential oncogenic action of tenascin-C in tumorigenesis", INT J BIOCHEM CELL BIOL, (2005), vol. 37, no. 5, pages 1066 - 1083 | - UDALOVA IA; RUHMANN M; THOMSON SJ; MIDWOOD KS, "Expression and immune function of tenascin-C", CRIT REV IMMUNOL, (2011), vol. 31, no. 2, pages 115 - 145 | - JONES FS; JONES PL, "The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling", DEV DYN, (2000), vol. 218, no. 2, pages 235 - 259 | - JOESTER A; FAISSNER A, "The structure and function of tenascins in the nervous system", MATRIX BIOL, (2001), vol. 20, no. 1, pages 13 - 22 | - IMANAKA-YOSHIDA K; MATSUURA R; ISAKA N; NAKANO T; SAKAKURA T; YOSHIDA T, "Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin- C expression", VIRCHOWS ARCH, (2001), vol. 439, no. 2, pages 185 - 190 | - GOLLEDGE J; CLANCY P; MAGUIRE J; LINCZ L; KOBLAR S, "The role of tenascin C in cardiovascular disease", CARDIOVASC RES, (2011), vol. 92, no. 1, pages 19 - 28 | - O'CONNELL JT; SUGIMOTO H; COOKE VG; MACDONALD BA; MEHTA AI; LEBLEU VS; DEWAR R; ROCHA RM; BRENTANI RR; RESNICK MB, "VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization", PROC NATL ACAD SCI USA, (2011), vol. 108, no. 38, pages 16002 - 16007 | - OSKARSSON T; ACHARYYA S; ZHANG XH; VANHARANTA S; TAVAZOIE SF; MORRIS PG; DOWNEY RJ; MANOVA-TODOROVA K; BROGI E; MASSAGUE J, "Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs", NAT MED, (2011), vol. 17, no. 7, pages 867 - 874 | - MIDWOOD KS; HUSSENET T; LANGLOIS B; OREND G, "Advances in tenascin-C biology", CELL MOL LIFE SCI, (2011), vol. 68, no. 19, pages 3175 - 3199 | - WEISEL JW, "Structure of fibrin: impact on clot stability", JOURNAL OF THROMBOSIS AND HAEMOSTASIS : JTH, (2007), vol. 5, no. 1, pages 116 - 124 | - MOSESSON MW, "Fibrinogen and fibrin structure and functions", JOURNAL OF THROMBOSIS AND HAEMOSTASIS : JTH, (2005), vol. 3, no. 8, pages 1894 - 1904 | - UGAROVA TP; YAKUBENKO VP, "Recognition of fibrinogen by leukocyte integrins", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, (2001), vol. 936, pages 368 - 385 | - FLICK MJ; DU X; WITTE DP; JIROUSKOVA M; SOLOVIEV DA; BUSUTTIL SJ; PLOW EF; DEGEN JL, "Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo", THE JOURNAL OF CLINICAL INVESTIGATION, (2004), vol. 113, no. 11, pages 1596 - 1606 | - JANMEY PA; WINER JP; WEISEL JW, "Fibrin gels and their clinical and bioengineering applications", JOURNAL OF THE ROYAL SOCIETY, INTERFACE / THE ROYAL SOCIETY, (2009), vol. 6, no. 30, pages 1 - 10 | - LORAND L; GRAHAM RM, "Transglutaminases: crosslinking enzymes with pleiotropic functions", NATURE REVIEWS. MOLECULAR CELL BIOLOGY, (2003), vol. 4, no. 2, pages 140 - 156 | - STANDEVEN KF; CARTER AM; GRANT PJ; WEISEL JW; CHERNYSH I; MASOVA L; LORD ST; ARIENS RA, "Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness", BLOOD, (2007), vol. 110, no. 3, pages 902 - 907 | - WEISEL JW, "The mechanical properties of fibrin for basic scientists and clinicians", BIOPHYS CHEM, (2004), vol. 112, no. 2-3, pages 267 - 276 | - SCHENSE JC; HUBBELL JA, "Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa", BIOCONJUG CHEM, (1999), vol. 10, no. 1, pages 75 - 81 | - PATTERSON J; MARTINO MM; HUBBELL JA, "Biomimetic materials in tissue engineering", MATERIALS TODAY, (2010), vol. 13, no. 1-2, pages 14 - 22 | - SAHNI A; KHORANA AA; BAGGS RB; PENG H; FRANCIS CW, "FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis", BLOOD, (2006), vol. 107, no. 1, pages 126 - 131 | - PENG H; SAHNI A; FAY P; BELLUM S; PRUDOVSKY I; MACIAG T; FRANCIS CW, "Identification of a binding site on human FGF-2 for fibrinogen", BLOOD, (2004), vol. 103, no. 6, pages 2114 - 2120 | - WERNER S; GROSE R, "Regulation of wound healing by growth factors and cytokines", PHYSIOLOGICAL REVIEWS, (2003), vol. 83, no. 3, pages 835 - 870 | - SAHNI A; ODRLJIN T; FRANCIS CW, "Binding of basic fibroblast growth factor to fibrinogen and fibrin", JOURNAL OF BIOLOGICAL CHEMISTRY, (1998), vol. 273, no. 13, pages 7554 - 7559 | - KRAMMER A; CRAIG D; THOMAS WE; SCHULTEN K; VOGEL V, "A structural model for force regulated integrin binding to fibronectin's RGD-synergy site", MATRIX BIOL, (2002), vol. 21, no. 2, pages 139 - 147 | - MAO Y; SCHWARZBAUER JE, "Fibronectin fibrillogenesis, a cell-mediated matrix assembly process", MATRIX BIOL, (2005), vol. 24, no. 6, pages 389 - 399 | - PANKOV R; YAMADA KM, "Fibronectin at a glance", J CELL SCI, (2002), vol. 115, pages 3861 - 3863 | - UPTON Z; WEBB H; HALE K; YANDELL CA; MCMURTRY JP; FRANCIS GL; BALLARD FJ, "Identification of vitronectin as a novel insulin-like growth factor-II binding protein", ENDOCRINOLOGY, (1999), vol. 140, no. 6, pages 2928 - 2931 | - KRICKER JA; TOWNE CL; FIRTH SM; HERINGTON AC; UPTON Z, "Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin", ENDOCRINOLOGY, (2003), vol. 144, no. 7, pages 2807 - 2815 | - SCHOPPET M; CHAVAKIS T; AL-FAKHRI N; KANSE SM; PREISSNER KT, "Molecular interactions and functional interference between vitronectin and transforming growth factor- beta", LAB INVEST, (2002), vol. 82, no. 1, pages 37 - 46 | - LEAHY DJ; HENDRICKSON WA; AUKHIL I; ERICKSON HP, "Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein", SCIENCE, (1992), vol. 258, no. 5084, pages 987 - 991 | - PENG Q; ZHUANG S; WANG M; CAO Y; KHOR Y; LI H, "Mechanical design of the third FnIII domain oftenascin-C", JOURNAL OF MOLECULAR BIOLOGY, (2009), vol. 386, no. 5, pages 1327 - 1342 | - YOKOSAKI Y; MATSUURA N; HIGASHIYAMA S; MURAKAMI I; OBARA M; YAMAKIDO M; SHIGETO N; CHEN J; SHEPPARD D, "Identification of the ligand binding site for the integrin alpha9 betal in the third fibronectin type III repeat of tenascin-C", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1998), vol. 273, no. 19, pages 11423 - 11428 | - WEBER P; ZIMMERMANN DR; WINTERHALTER KH; VAUGHAN L, "Tenascin-C binds heparin by its fibronectin type III domain five", J BIOL CHEM, (1995), vol. 270, no. 9, pages 4619 - 4623 | - WEISEL JW; STAUFFACHER CV; BULLITT E; COHEN C, "A model for fibrinogen: domains and sequence", SCIENCE, (1985), vol. 230, no. 4732, pages 1388 - 1391 | - ODRLJIN TM; SHAINOFF JR; LAWRENCE SO; SIMPSON-HAIDARIS PJ, "Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain", BLOOD, (1996), vol. 88, no. 6, pages 2050 - 2061 | - MARDON HJ; GRANT KE, "The role of the ninth and tenth type III domains of human fibronectin in cell adhesion", FEBS LETT, (1994), vol. 340, no. 3, pages 197 - 201 | - MOULD AP; ASKARI JA; AOTA S; YAMADA KM; IRIE A; TAKADA Y; MARDON HJ; HUMPHRIES MJ, "Defining the topology of integrin alpha5betal-fibronectin interactions using inhibitory anti-alpha5 and anti-beta monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit", J BIOL CHEM, (1997), vol. 272, no. 28, pages 17283 - 17292 | - DANEN EH; AOTA S; VAN KRAATS AA; YAMADA KM; RUITER DJ; VAN MUIJEN GN, "Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta I", J BIOL CHEM, (1995), vol. 270, no. 37, pages 21612 - 21618 | - VAN DER WALLE CF; ALTROFF H; MARDON HJ, "Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activity", PROTEIN ENGINEERING, (2002), vol. 15, no. 12, pages 1021 - 1024 | - GURTNER GC; WERNER S; BARRANDON Y; LONGAKER MT, "Wound repair and regeneration", NATURE, (2008), vol. 453, no. 7193, pages 314 - 321 | - HERBERT SP; STAINIER DY, "Molecular control of endothelial cell behaviour during blood vessel morphogenesis", NATURE REVIEWS. MOLECULAR CELL BIOLOGY, (2011), vol. 12, no. 9, pages 551 - 564 | - KARP JM; LENG TEO GS, "Mesenchymal stem cell homing: the devil is in the details", CELL STEM CELL, (2009), vol. 4, no. 3, pages 206 - 216 | - EMING SA; HAMMERSCHMIDT M; KRIEG T; ROERS A, "Interrelation of immunity and tissue repair or regeneration", SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, (2009), vol. 20, no. 5, pages 517 - 527 | - LUTOLF MP; HUBBELL JA, "Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering", NAT BIOTECHNOL, (2005), vol. 23, no. 1, pages 47 - 55 | - ATALA A, "Advances in tissue and organ replacement", CURR STEM CELL RES THER, (2008), vol. 3, no. 1, pages 21 - 31 | - HUEBSCH N; MOONEY DJ, "Inspiration and application in the evolution of biomaterials", NATURE, (2009), vol. 462, no. 7272, pages 426 - 432 | - AFFOLTER M; BASLER K, "The Decapentaplegic morphogen gradient: from pattern formation to growth regulation", NATURE REVIEWS. GENETICS, (2007), vol. 8, no. 9, pages 663 - 674 | - VILCEK J; FELDMANN M, "Historical review: Cytokines as therapeutics and targets of therapeutics", TRENDS IN PHARMACOLOGICAL SCIENCES, (2004), vol. 25, no. 4, pages 201 - 209 | - CROSS M; DEXTER TM, "Growth factors in development, transformation, and tumorigenesis", CELL, (1991), vol. 64, no. 2, pages 271 - 280 | - OVIEDO NJ; BEANE WS, "Regeneration: The origin of cancer or a possible cure?", SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, (2009), vol. 20, no. 5, pages 557 - 564 | - SCHAFER M; WERNER S, "Cancer as an overhealing wound: an old hypothesis revisited", NATURE REVIEWS. MOLECULAR CELL BIOLOGY, (2008), vol. 9, no. 8, pages 628 - 638 | - WRZESINSKI SH; WAN YY; FLAVELL RA, "Transforming growth factor-beta and the immune response: implications for anticancer therapy", CLINICAL CANCER RESEARCH: AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, (2007), vol. 13, no. 18, pages 5262 - 5270 | - BIERIE B; MOSES HL, "Transforming growth factor beta (TGF-beta) and inflammation in cancer", CYTOKINE & GROWTH FACTOR REVIEWS, (2010), vol. 21, no. 1, pages 49 - 59 | - UNTERGASSER G; GANDER R; LILG C; LEPPERDINGER G; PLAS E; BERGER P, "Profiling molecular targets of TGF-betal in prostate fibroblast-to-myofibroblast transdifferentiation", MECHANISMS OF AGEING AND DEVELOPMENT, (2005), vol. 126, no. 1, pages 59 - 69 | - WESCHE J; HAGLUND K; HAUGSTEN EM, "Fibroblast growth factors and their receptors in cancer", THE BIOCHEMICAL JOURNAL, (2011), vol. 437, no. 2, pages 199 - 213 | - LOHELA M; BRY M; TAMMELA T; ALITALO K, "VEGFs and receptors involved in angiogenesis versus lymphangiogenesis", CURRENT OPINION IN CELL BIOLOGY, (2009), vol. 21, no. 2, pages 154 - 165 | - ISSA A; LE TX; SHOUSHTARI AN; SHIELDS JD; SWARTZ MA, "Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype", CANCER RESEARCH, (2009), vol. 69, no. 1, pages 349 - 357 | - WANG Z; AHMAD A; LI Y; KONG D; AZMI AS; BANERJEE S; SARKAR FH, "Emerging roles of PDGF-D signaling pathway in tumor development and progression", BIOCHIMICA ET BIOPHYSICA ACTA, (2010), vol. 1806, no. 1, pages 122 - 130 | - LAM CT; YANG ZF; LAU CK; TAM KH; FAN ST; POON RT, "Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma", CLINICAL CANCER RESEARCH: AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, (2011), vol. 17, no. 10, pages 3123 - 3133 | - KRAMER F; STOVER T; WARNECKE A; DIENSTHUBER M; LENARZ T; WISSEL K, "BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity", JOURNAL OF NEURO-ONCOLOGY, (2010), vol. 98, no. 1, pages 31 - 39 | - LUTOLF MP; LAUER-FIELDS JL; SCHMOEKEL HG; METTERS AT; WEBER FE; FIELDS GB; HUBBELL JA, "Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics", PROC NATL ACAD SCI USA, (2003), vol. 100, no. 9, pages 5413 - 5418 | - EHRBAR M; RIZZI SC; HLUSHCHUK R; DJONOV V; ZISCH AH; HUBBELL JA; WEBER FE; LUTOLF MP, "Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering", BIOMATERIALS, (2007), vol. 28, no. 26, pages 3856 - 3866 | - MOSESSON MW, "Fibrinogen and fibrin structure and functions", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, (2005), vol. 3, no. 8, pages 1894 - 1904 | - MARTINO MM; MOCHIZUKI M; ROTHENFLUH DA; REMPEL SA; HUBBELL JA; BARKER TH, "Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability", BIOMATERIALS, (2009), vol. 30, no. 6, pages 1089 - 1097 | - EHRBAR M; RIZZI SC; SCHOENMAKERS RG; MIGUEL BS; HUBBELL JA; WEBER FE; LUTOLF MP, "Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions", BIOMACROMOLECULES, (2007), vol. 8, no. 10, pages 3000 - 3007 | - HANFT JR; POLLAK RA; BARBUL A; VAN GILS C; KWON PS; GRAY SM; LYNCH CJ; SEMBA CP; BREEN TJ, "Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers", J WOUND CARE, (2008), vol. 17, no. 1, pages 30 - 32,34-37 | - ROBSON MC; PHILLIPS TJ; FALANGA V; ODENHEIMER DJ; PARISH LC; JENSEN JL; STEED DL, "Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers", WOUND REPAIR REGEN, (2001), vol. 9, no. 5, pages 347 - 352 | - ROBSON MC; PHILLIPS LG; LAWRENCE WT; BISHOP JB; YOUNGERMAN JS; HAYWARD PG; BROEMELING LD; HEGGERS JP, "The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores", ANN SURG, (1992), vol. 216, no. 4, pages 401 - 406 | - ROBSON MC; PHILLIPS LG; THOMASON A; ROBSON LE; PIERCE GF, "Platelet- derived growth factor BB for the treatment of chronic pressure ulcers", LANCET, (1992), vol. 339, no. 8784, pages 23 - 25 | - SULLIVAN SR; UNDERWOOD RA; GIBRAN NS; SIGLE RO; USUI ML; CARTER WG; OLERUD JE, "Validation of a model for the study of multiple wounds in the diabetic mouse (db/db", PLAST RECONSTR SURG, (2004), vol. 113, no. 3, pages 953 - 960 | - DAVIDSON JM, "Animal models for wound repair", ARCH DERMATOL RES, (1998), vol. 290, pages I - 11 | - CHAN RK; LIU PH; PIETRAMAGGIORI G; IBRAHIM SI; HECHTMAN HB; ORGILL DP, "Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice", J BURN CARE RES, (2006), vol. 27, no. 2, pages 202 - 205 | - GALIANO RD; TEPPER OM; PELO CR; BHATT KA; CALLAGHAN M; BASTIDAS N; BUNTING S; STEINMETZ HG; GURTNER GC, "Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells", AM J PATHOL, (2004), vol. 164, no. 6, pages 1935 - 1947 | - HOLLINGER JO; HART CE; HIRSCH SN; LYNCH S; FRIEDLAENDER GE, "Recombinant human platelet-derived growth factor: biology and clinical applications", J BONE JOINT SURG AM, (2008), vol. 90, no. 1, pages 48 - 54 | - MUSCHLER GF; RAUT VP; PATTERSON TE; WENKE JC; HOLLINGER JO, "The design and use of animal models for translational research in bone tissue engineering and regenerative medicine", TISSUE ENG PART B REV, vol. 16, no. 1, pages 123 - 145 | - HOLLINGER JO; KLEINSCHMIDT JC, "The critical size defect as an experimental model to test bone repair materials", J CRANIOFAC SURG, (1990), vol. 1, no. 1, pages 60 - 68 | - SCHMOEKEL HG; WEBER FE; SCHENSE JC; GRATZ KW; SCHAWALDER P; HUBBELL JA, "Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices", BIOTECHNOL BIOENG, (2005), vol. 89, no. 3, pages 253 - 262 | - GAUTSCHI OP; FREY SP; ZELLWEGER R, "Bone morphogenetic proteins in clinical applications", ANZ J SURG, (2007), vol. 77, no. 8, pages 626 - 631 | - JONES LL; OUDEGA M; BUNGE MB; TUSZYNSKI MH, "Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury", THE JOURNAL OF PHYSIOLOGY, (2001), vol. 533, pages 83 - 89 | - ANDREWS MR; CZVITKOVICH S; DASSIE E; VOGELAAR CF; FAISSNER A; BLITS B; GAGE FH; FFRENCH-CONSTANT C; FAWCETT JW, "Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration", THE JOURNAL OF NEUROSCIENCE: THE OFFICIAL JOURNAL OF THE SOCIETY FOR NEUROSCIENCE, (2009), vol. 29, no. 17, pages 5546 - 5557 | - TYSSELING-MATTIACE VM; SAHNI V; NIECE KL; BIRCH D; CZEISLER C; FEHLINGS MG; STUPP SI; KESSLER JA, "Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury", THE JOURNAL OF NEUROSCIENCE: THE OFFICIAL JOURNAL OF THE SOCIETY FOR NEUROSCIENCE, (2008), vol. 28, no. 14, pages 3814 - 3823 | - SHARP J; FRAME J; SIEGENTHALER M; NISTOR G; KEIRSTEAD HS, "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury", STEM CELLS, (2010), vol. 28, no. 1, pages 152 - 163 |